Mirtazapine for pruritus

Journal of Pain and Symptom Management

Volumn 25, Issue 3, 2003, Pages 288-291

  Davis, Mellar P ^a   Frandsen, Jan L ^a   Walsh, Declan ^a   Andresen, Steven ^b   Taylor, Sandy ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c Hospice of the Western Reserve Inc   (United States)

Author keywords

Cholestasis; Lymphoma; Mirtazapine; Pruritus; Renal failure

Indexed keywords

MIRTAZAPINE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; MALE; PRURITUS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHOLESTASIS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; KIDNEY FAILURE; MALE; MIANSERIN; MIDDLE AGED; NEOPLASMS; PRURITUS;

EID: 0037333884     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(02)00645-0     Document Type: Article

References (16)

1. Seiz A.M., Yarbro C.H. Pruritus. Yarbro C.H., Hansen Frogge M., Goodman M. Cancer symptom management. 2nd ed:1999;148-160 Jones and Bartlett, Boston.
2. Scott C.L. Pruritus. Kuebler K.K., Berry P.H., Berry D.E. End of life care. clinical practice guidelines:2000;409-417 Saunders, Philadelphia.
3. Krajnik M., Zylicz Z. Understanding pruritus in systemic disease. J Pain Symptom Manage. 21(2):2001;151-168.
4. Jones E.A., Bergasa N.V. The pruritus of cholestasis. Hepatology. 29(4):1999;1003-1006.
5. Yamaguchi T., Nagasawa T., Satoh M., Kuraishi Y. Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice. Neurosci Res. ;35(2):1999;77-83. (Suppl).
6. Balaskas EV, Bamihas GI, Karamouzis M, et al. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 1998,78(4):395-402.
7. Larijani G.E., Goldberg M.E., Rogers K.H. Treatment of opioid-induced pruritus with ondasetron. report of four patients Pharmacotherapy. 16(5):1996;958-960.
8. Zylicz Z., Smits C., Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage. 16(2):1998;121-124.
9. 3) receptor antagonist: effectiveness of ondansetron Pain. 61:1995;33-37.
10. 3 receptor antagonist and its applications in CNS-related disorders CNS Drug Rev. 7(2):2001;199-213.
11. Wilde M.I., Markham A. Ondansetron. a review of its pharmacology and preliminary clinical findings in novel applications Drugs. 52(5):1996;773-794.
12. Tennyson H., Levine N. Neurotropic and psychotropic drugs in dermatology. Dermatol Clin. 19(1):2001;179-197.
13. Diehn F., Tefferi A. Pruritus in polycythaemia vera. prevalence, laboratory correlates and management Br J Haematol. 155(3):2001;619-621.
14. Yeh H.M., Chen L.K., Lin C.J.et al. Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. Anesthe Analg. 91(1):2000;172-175.
15. Puzantian T. Mirtazapine, an antidepressant. Am J Health Syst Pharm. 55(1):1998;44-49.
16. Davis M., Dickerson E.D., Pappagallo M.et al. Mirtazapine. heir apprarent to amitriptyline? Am J Hospice Pall Care. 18(1):2001;42-46.